In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Clozapine, Clozaril, Azaleptin, Leponex, Fazaclo, Froidir, Denzapine, Zaponex Drug Master File in Korea (Clozapine, Clozaril, Azaleptin, Leponex, Fazaclo, Froidir, Denzapine, Zaponex KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Clozapine, Clozaril, Azaleptin, Leponex, Fazaclo, Froidir, Denzapine, Zaponex. The MFDS reviews the Clozapine, Clozaril, Azaleptin, Leponex, Fazaclo, Froidir, Denzapine, Zaponex KDMF as part of the drug registration process and uses the information provided in the Clozapine, Clozaril, Azaleptin, Leponex, Fazaclo, Froidir, Denzapine, Zaponex KDMF to evaluate the safety and efficacy of the drug.
After submitting a Clozapine, Clozaril, Azaleptin, Leponex, Fazaclo, Froidir, Denzapine, Zaponex KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Clozapine, Clozaril, Azaleptin, Leponex, Fazaclo, Froidir, Denzapine, Zaponex API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Clozapine, Clozaril, Azaleptin, Leponex, Fazaclo, Froidir, Denzapine, Zaponex suppliers with KDMF on PharmaCompass.